Patent ID: 11866503
Assignee: REGENERON PHARMACEUTICALS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 16:
17. The method of claim 1, wherein the IL-33 antagonist comprises a HCVR comprising an amino acid sequence with 4 or fewer amino acid substitutions relative to SEQ ID NO: 274 and a LCVR comprising an amino acid sequence with 4 or fewer amino acid substitutions relative to SEQ ID NO: 282, and the IL-4R antagonist comprises a HCVR comprising an amino acid sequence with 4 or fewer amino acid substitutions relative to SEQ ID NO: 337 and a LCVR comprising an amino acid sequence with 4 or fewer amino acid substitutions relative to SEQ ID NO: 338.